General Information
Takeda DM2 006
A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate Treatment with SYR-472 in Subjects with Type 2 Diabetes
| Protocol | |
|---|---|
| Identifier | 01-06-TL-SYR472-006 |
| UID | 47ac0f39-7bb4-4102-8a0f-35c05beab0c8 |
| Status | Done - Archived |
| Phase | 2 |
| Category | Diabetes Type 2 |
| Launch Year | 2007 |
| NCT Number | - |
| Created | 2012-05-07 13:51 |
| Last Updated | 2012-05-07 13:51 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | No | |
| Enrollment Open | No | |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2007-10-08 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | No | |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Zolnouni, Parvaneh | PZolnouni | No |
| Recruiter | - | No | |
| Coordinator | - | No | |
| Regulatory | - | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Takeda |
|---|---|
| Division | Takeda |
| Team | Takeda |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
